Requirement of a carbon spacer in benzyl isothiocyanate-mediated cytotoxicity and MAPK activation in head and neck squamous cell carcinoma

被引:42
作者
Lui, VWY
Wentzel, AL
Xiao, D
Lew, KL
Singh, SV
Grandis, JR [1 ]
机构
[1] Univ Pittsburgh, Sch Med, Dept Otolaryngol, Pittsburgh, PA 15213 USA
[2] Univ Pittsburgh, Sch Med, Dept Pharmacol, Pittsburgh, PA 15213 USA
[3] Univ Pittsburgh, Inst Canc, Pittsburgh, PA 15213 USA
关键词
D O I
10.1093/carcin/bgg127
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Cruciferous vegetable-derived isothiocyanates (ITCs; chemical structure: R-N=C=S) are highly effective in affording protection against chemically induced cancers in animal models. Here, we studied the antitumor effects of benzyl isothiocyanate (BITC; Ph-CH2-N=C=S), the predominant ITC compound in broccoli, on head and neck squamous cell carcinoma (HNSCC) cell lines. Proliferation, apoptosis and immunoblotting assays were used to determine the effects and mechanism of several ITCs on HNSCC cells. The IC50 for BITC (24 h treatment) in two of the HNSCC cell lines was similar to22 and 17 muM, respectively. Interestingly, phenyl isothiocyanate (PITC; Ph-N=C=S), which is a close structural analog of BITC but lacks a -CH2- spacer that links the aromatic ring to N=C=S moiety, did not result in significant killing of the HNSCC cells in this dose range. BITC (but not PITC) caused activation of caspase 3 and PARP cleavage. Within 20 min of treatment, BITC (but not PITC) induced a rapid activation of p38 MAPK. In addition, BITC (but not PITC) treatment resulted in the activation of p44/42 MAPK. Co-treatment with a specific p38 MAPK inhibitor, SB203580, or an inhibitor of the MEK/MAPK pathway, U0126, partially rescued cells from BITC-induced killing. Our results show that minor structural differences in ITCs can be crucial for the antiproliferative activity of ITCs and that BITC may be a promising chemopreventive as well as therapeutic agent in HNSCC.
引用
收藏
页码:1705 / 1712
页数:8
相关论文
共 40 条
[11]  
León X, 1999, HEAD NECK-J SCI SPEC, V21, P204, DOI 10.1002/(SICI)1097-0347(199905)21:3<204::AID-HED4>3.0.CO
[12]  
2-7
[13]  
LEONARD TB, 1981, TOXICOL APPL PHARM, V60, P527, DOI 10.1016/0041-008X(81)90339-2
[14]   New therapeutic strategies for the treatment and prevention of head and neck cancer [J].
Lingen, MW ;
Emami, B ;
Clark, JI .
EXPERT OPINION ON INVESTIGATIONAL DRUGS, 2000, 9 (12) :2855-2872
[15]  
MORSE MA, 1989, CANCER RES, V49, P2894
[16]  
MORSE MA, 1991, CANCER RES, V51, P1846
[17]  
MORSE MA, 1989, CANCER RES, V49, P549
[18]   EFFECTS OF ALKYL CHAIN-LENGTH ON THE INHIBITION OF NNK-INDUCED LUNG NEOPLASIA IN A/J MICE BY ARYLALKYL ISOTHIOCYANATES [J].
MORSE, MA ;
EKLIND, KI ;
AMIN, SG ;
HECHT, SS ;
CHUNG, FL .
CARCINOGENESIS, 1989, 10 (09) :1757-1759
[19]  
Nakamura Y, 2000, CANCER RES, V60, P219
[20]  
PROCHASKA HJ, 1988, CANCER RES, V48, P4776